Novoseven 1 mg Injection 1's

Your doctor may prescribe this medicine to help manage the following conditions:
 

• Haemophilia A or B with inhibitors: Novoseven 1 mg Injection helps control and prevent bleeding episodes in patients who have developed inhibitors (antibodies) against clotting factors VIII or IX by bypassing the blocked clotting pathway.
• Congenital factor VII deficiency: It replaces the missing activated clotting factor VII, helping restore normal blood clot formation and control bleeding episodes.
• Glanzmann's thrombasthenia: This medicine is used to treat bleeding episodes and to prevent bleeding during surgical or dental procedures in patients withGlanzmann's thrombasthenia, particularly when platelet transfusions are ineffective or unsuitable.
• Prevention of surgical bleeding: Novoseven 1 mg Injection is administered before, during, or after surgery and other invasive procedures to reduce the risk of excessive bleeding in patients with eligible bleeding disorders.
   

Novoseven 1 mg Injection is used to treat bleeding and to prevent bleeding after surgery or other important treatments. It is used in people who were born with haemophilia (inherited bleeding disorder) and did not normally respond to factors VIII or IX treatment, has acquired haemophilia, Factor VII deficiency, or Glanzmann’s thrombasthenia (a bleeding disorder), and the condition cannot be treated effectively with platelet transfusion, or if platelets are not readily available. Novoseven 1 mg Injection may also be given to treat heavy bleeding after delivery of the baby, even if the mother does not have a bleeding disorder. Novoseven 1 mg Injection contains Eptacog alfa, a blood coagulation factor that works by making the blood clot at the site of bleeding when the body’s own clotting factors are not working. Early treatment with Novoseven 1 mg Injection reduces the amount and duration of bleeding. Novoseven 1 mg Injection works in all types of bleeds, including joint bleeds.

• Follow your doctor’s instructions on the dosage and timing of this medication to ensure safe and effective use.
• Novoseven 1 mg Injection will be administered by a healthcare professional. In some cases, it may be given to use at home. Follow your doctor’s instructions if you use this injection at home.
• Do not use if the solution is cloudy, contains particles, or if the vial is damaged.

• Stay physically active: Engage in low-impact exercises such as walking, swimming, or cycling to strengthen the muscles around your joints and help reduce the risk of bleeding. Avoid high-impact or contact sports unless approved by your doctor.
• Maintain a healthy body weight: Keeping your weight within a healthy range reduces stress on your joints and may help decrease the frequency of joint bleeding episodes.
• Practice good oral hygiene: Brush your teeth with a soft-bristled toothbrush and floss gently to maintain healthy gums and reduce the risk of oral bleeding.
• Schedule regular dental check-ups and inform your dentist about your bleeding disorder.
• Avoid medicines that increase bleeding risk: Unless specifically prescribed by your doctor, avoid aspirin, ibuprofen, naproxen, and other NSAIDs, as they can interfere with normal clotting. Speak with your healthcare provider about safer alternatives for pain relief.
• Protect yourself from injuries: Use appropriate protective equipment during physical activities, avoid situations that increase your risk of trauma, and seek medical advice promptly if you experience signs of internal bleeding or joint swelling.
   

• Inspect the solution before administration: After reconstitution, the solution should be clear and colourless. Do not use it if it appears cloudy, discoloured, or contains visible particles.
• Use proper injection technique: Rotate injection sites whenever possible to reduce the risk of vein irritation, scarring, or local injection-site reactions.
• Use sterile equipment every time: Never reuse needles, syringes, infusion sets, or transfer devices. Always use new sterile equipment for each administration to minimise the risk of infection.
• Maintain a treatment record: Keep a log of each infusion, including the date, dose, batch (lot) number, and reason for treatment (such as a bleeding episode or routine prophylaxis), and share it with your healthcare provider during follow-up visits.
• Carry medical identification: Always carry a medical alert card or bracelet stating that you have a bleeding disorder and are receiving Novoseven 1 mg Injection so appropriate treatment can be provided in an emergency.